Results 41 to 50 of about 9,644 (307)

Hypertrophic Cardiomyopathy - Past, Present and Future [PDF]

open access: yes, 2017
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy with a prevalence of 1 in 500 in the general population. Since the first pathological case series at post mortem in 1957, we have come a long way in its understanding, diagnosis ...
Brock   +5 more
core   +2 more sources

Alcohol septal ablation in hypertrophic cardiomyopathy

open access: yesGlobal Cardiology Science and Practice, 2018
Alcohol septal ablation (ASA) has become an alternative to surgical myectomy in obstructive hypertrophic cardiomyopathy since it was first introduced in 1994 by Sigwart. The procedure alleviates symptoms by producing a limited infarction of the upper interventricular septum, resulting in a decrease in left ventricular outflow tract (LVOT) gradient. The
Mateo, Juan José Santos   +1 more
openaire   +3 more sources

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy [PDF]

open access: yesCurrent Cardiology Reviews, 2008
Since its original description in 1994, alcohol septal ablation (ASA) has emerged as a minimally invasive modality for treatment of hypertrophic obstructive cardiomyopathy compared to surgical myomectomy. This catheter-based intervention relies on the injection of absolute alcohol into the septal perforator to induce a controlled infarction of the ...
El Masry, Hicham, Breall, Jeffrey A
openaire   +2 more sources

Septal alcohol ablation in patients with hypertrophic cardiomyopathy and left ventricular outflow tract obstruction

open access: yesКардиоСоматика
BACKGROUND: Hypertrophic cardiomyopathy is a primarily genetically determined myocardial disease characterized by pronounced, often asymmetric, myocardial hypertrophy that results in diastolic dysfunction and left ventricular outflow tract obstruction ...
Mariia S. Nozdriakova   +5 more
doaj   +1 more source

Excess mortality and sex differences in outcome in hypertrophic cardiomyopathy: a European multicentre study [PDF]

open access: yes, 2019
Background. Contemporary survival studies in hypertrophic cardiomyopathy (HCM) have shown that the prognosis for most individuals with the disease is much better than described previously, but it remains unclear whether HCM conveys an excess mortality ...
Lorenzini, Massimiliano <1983>
core   +1 more source

Septal alcoholization in hypertrophic cardiomyopathy: about 11 cases

open access: yesThe Pan African Medical Journal, 2017
Outcomes of septal alcoholization in hypertrophic obstructive cardiomyopathy are not enough studied in all centers. The purpose of this study was to determine the outcomes of septal alcoholization in hypertrophic obstructive cardiomyopathy in our ...
Yibar Kambire   +3 more
doaj   +1 more source

Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy- Is Myocardial Contrast Echocardiography Mandatory?

open access: yesJournal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2022
Alcohol septal ablation (ASA) is an effective treatment for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). Although routine use of myocardial contrast echocardiography (MCE) in guiding ASA has been recommended by guidelines, it has not come ...
Sridhar Lakshmana Sastry   +4 more
doaj   +1 more source

A Path to Implement Precision Child Health Cardiovascular Medicine. [PDF]

open access: yes, 2017
Congenital heart defects (CHDs) affect approximately 1% of live births and are a major source of childhood morbidity and mortality even in countries with advanced healthcare systems. Along with phenotypic heterogeneity, the underlying etiology of CHDs is
Brian Reemtsen   +8 more
core   +2 more sources

Hypertrophic obstructive cardiomyopathy: alcohol septal ablation [PDF]

open access: yes, 2017
Alcohol septal ablation (ASA) was introduced in 1994 as an alternative to septal myectomy for patients with hypertrophic obstructive cardiomyopathy and symptoms refractory to medical therapy.
Fifer, Michael A., Sigwart, Ulrich
core  

Adaptive 4D‐Printed Vascular Stents With Low‐Temperature‐Activated and Intelligent Deployment

open access: yesAdvanced Functional Materials, EarlyView.
Microarchitected coronary artery stents were fabricated using a polycaprolactone (PCL)‐based shape memory polymer (SMP) composite via projection micro‐stereolithography (PµSL) 4D printing. By incorporating diethyl phthalate (DEP) as a plasticizer, the thermal transition temperature (Ttran) was modulated to about 37°C, enabling rapid and autonomous ...
Yannan Li   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy